Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome

被引:0
|
作者
Fumihiro Goto
Toru Uchiyama
Yumiko Nakazawa
Kohsuke Imai
Toshinao Kawai
Masafumi Onodera
机构
[1] National Center for Child Health and Development,Department of Human Genetics
[2] Tokyo Medical and Dental University,Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences
来源
Journal of Clinical Immunology | 2017年 / 37卷
关键词
Rapamycin; Hematopoietic Stem Cell Transplantation; Rapamycin Treatment; Quantitative Polymerase Chain Reaction Analysis; mTOR Inhibitor Rapamycin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:347 / 350
页数:3
相关论文
共 50 条
  • [21] A requirement for PI3K in γδ T cell development
    Sumaria, N.
    Pang, D. J.
    Grandjean, C. L.
    Neves, J. F.
    Stoenchev, K. V.
    Silva-Santos, B.
    Pennington, D. J.
    IMMUNOLOGY, 2013, 140 : 160 - 160
  • [22] Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome
    Rao, V. Koneti
    Kulm, Elaine
    Grossman, Jennifer
    Buchbinder, David
    Chong, Hey
    Bradt, Jason
    Webster, Sharon
    Sediva, Anna
    Dalm, Virgil A.
    Uzel, Gulbu
    BLOOD ADVANCES, 2024, 8 (12) : 3092 - 3108
  • [23] Activated PI3Kδ syndrome - reviewing challenges in diagnosis and treatment
    Vanselow, Sven
    Wahn, Volker
    Schuetz, Catharina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] ACTIVATED PI3-KINASE DELTA SYNDROME (APDS) AND T-CELL LYMPHOMA
    Krummenacher, Matthew
    Banovic, Tatjana
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 41 - 41
  • [25] Disseminated abscesses due to Mycoplasma faucium in a patient with activated PI3Kδ syndrome type 2
    Dominguez-Pinilla, Nerea
    Allende, Luis M.
    Rosain, Jeremie
    del Carmen Gallego, Maria
    Chaves, Fernando
    Deswarte, Caroline
    Viedma, Esther
    de Inocencio Arocena, Jaime
    Ruiz-Contreras, Jesus
    Bustamante, Jacinta
    Ignacio Gonzalez-Granado, Luis
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1796 - +
  • [26] THERAPEUTIC POTENTIAL OF DUAL PI3K DELTA/GAMMA INHIBITION IN T-CELL LYMPHOMAS
    Vakkalanka, S.
    Viswanadha, S.
    Govindarajulu, B.
    Prasanna, R.
    Veeraraghavan, S.
    Nagarathnam, D.
    HAEMATOLOGICA, 2013, 98 : 407 - 407
  • [27] The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function
    Pompura, Saige L.
    Dominguez-Villar, Margarita
    JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (06) : 1065 - 1076
  • [28] The PI3K p110δ controls T-cell development, differentiation and regulation
    Patton, D. T.
    Garcon, F.
    Okkenhaug, K.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 167 - 171
  • [29] PI3K signaling in B cell and T cell biology
    Okkenhaug, Klaus
    Turner, Martin
    Gold, Michael R.
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [30] HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HYPER IGM SYNDROME WITH ACTIVATED PI3K DELTA VARIANT
    Garcia, G.
    Zarate-Hernandez, C.
    Curiel, B.
    Gonzalez-Diaz, S.
    Rosado, J. Uc
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S164 - S164